Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132393) titled 'Clinical Efficacy of Intradermal Botulinum Toxin Type A in Erythematotelangiectatic Rosacea and Its Impact on Skin Microbiome: A Pilot Study' on Sept. 14.
Study Type: Interventional study
Study Design:
Non randomized control
Primary Sponsor: Shandong Medical and Pharmaceutical University Hospital
Condition:
Erythematocytic telangiectatic rosacea
Intervention:
Control group:N/A
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2026-01-08
Target Sample Size: Control group:30;treatment group:30;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj...